14th Annual Coastal Dermatology Symposium

14th Annual Coastal Dermatology Symposium is organized by Global Academy For Medical Education and will be held from Oct 04 - 06, 2018 at Monterey Plaza Hotel & Spa, Monterey, California, United States of America.

The target audience for this medical event is Dermatologists, dermatology residents, family practitioners, physician assistants, nurse practitioners, nurses, and other healthcare professionals who treat diseases of the skin. This CME Conference has been approved for a maximum of 15.75 AMA PRA Category 1 Credits.

Learning Objectives :
At the conclusion of this live activity, participants should be better able to:
• Design a comprehensive treatment plan for acne, rosacea and contact dermatitis patients based on clinical guidelines, incorporating pharmacologic and nonpharmacologic strategies.
• Identify risk factors and design treatment plans for actinic keratosis and seborrheic keratosis.
• Differentiate and develop treatment plans for actinic keratosis, and seborrheic keratosis.
• Describe the pathophysiology of psoriasis and the associated comorbidities of the disease.
• Diagnose and treat patients with psoriasis appropriately, based on current clinical guidelines.
• Design treatment strategies that incorporate biologic therapies in the management of appropriately selected patients with psoriasis.
• Incorporate strategies for use of new therapies aimed at blocking the inflammatory mediators of atopic dermatitis, both mild to moderate and moderate to severe.
• Integrate checklists, evaluation tools, and dermoscopy into examination of suspect skin lesions to produce an accurate diagnosis and guide treatment decisions.
• Distinguish key characteristics of emerging and newly approved agents for treating skin infections
• Describe the evolving pathophysiology and effects of chronic itch on quality of life.
• Identify and treat onychomycosis and tinea in appropriately selected patients.
• Design treatment strategies appropriate for pediatric patients with common dermatologic conditions.
• Identify characteristics in pediatric patients that suggest increased risk for conversion of benign moles to dysplastic nevi or melanoma.

Time: 6:30 am to 12:30 pm
Prices:
Thru 6/30/18 See Website for all pricing: USD 495.0,
7/1/2018 to 9/7/2018 See Website for all pricing: USD 595.0,
9/8/2018 See Website for all pricing: USD 695.0

Speakers: Conference Director: Joseph F. Fowler, Jr, MD, University of Louisville School of Medicine, Associate Director: Vincent A. DeLeo, MD,  Keck School of Medicine University of Southern California, Timothy G. Berger, MD, University of California San Francisco School of Medicine, Andrew Blauvelt, MD, MBA, Oregon Medical Research Center, Roger I. Ceilley, MD, Carver College of Medicine, University of Iowa, Julie C. Harper, University of Alabama-Birmingham, J. Mark Jackson, MD, University of Louisville School of Medicine, Moise L. Levy, MD, Baylor College of Medicine and UT Southwestern Medical School, Trilokraj Tesjavi, MBBS, MD, Michigan Medicine, University of Michigan